Progressive multifocal leukoencephalopathy after natalizumab discontinuation: few and true?
MS Center Amsterdam, Department of Radiology, Nuclear Medicine, and PET Research, VU University Medical Center, Amsterdam, the Netherlands.
Mike P
MP
Wattjes
Joep
J
Killestein
D016907:Adverse Drug Reaction Reporting Systems / Q000639:trends*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D028761:Withholding Treatment / Q000639:trends*
D061067:Antibodies, Monoclonal, Humanized